Related Materials
In the report “Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV — CDC Recommendations, United States, 2025,” the following errors occurred:
On page 6, in the second column of Box 2, the third bullet should have read, “For persons with long-acting injectable PrEP ARV exposure during the past 6 months, a diagnostic HIV nucleic acid test (NAT) is recommended at the initial medical evaluation, in addition to an Ag/Ab HIV test (NEW*: good practice statement, indirect data; existing recommendation).”
On page 14, in the second column, the second bullet should have read, “For persons with long-acting injectable PrEP ARV exposure during the past 6 months, a diagnostic HIV nucleic acid test (NAT) is recommended at the initial medical evaluation, in addition to an Ag/Ab HIV test (good practice statement, indirect data; existing recommendation).”
On page 15, the fourth sentence in the first paragraph should have read, “Certain experts would include an HIV NAT in nPEP baseline testing, especially if the person has recently taken oral ARVs or had a cabotegravir injection during the past **6 months.**”
Where this page came from
This page was imported from Centers for Disease Control and Prevention. Material produced by the Centers for Disease Control and Prevention is a work of the United States government and is in the public domain.
Nobody has written it yet — it is the source material at a new address, which is why search engines are asked to skip it and why no one earns from it. It is up for grabs: take it on, and it is yours to rewrite and to earn from.
이용 허락: CC0 1.0 (퍼블릭 도메인) · 출처 www.cdc.gov
1
0
0
0
코멘트
